UBS O'Connor »

Carmell Therapeutics Corp - US shares owned by UBS O'Connor

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-09-30 $33k 371k 0.09
2024-03-31 $57k 371k 0.15
2023-09-30 $91k 371k 0.25

More positions owned by UBS O'Connor

Spirit Aer Comcl (SPR)
Equity Comsh (EQC)
Revance Th Note1 (Principal)
Peloton In Note2 (Principal)
Spirit Air Note1 (Principal)
Ryanair Ho Spons (RYAAY)
3M Company (MMM)
Mattel (MAT)
Parker-Hannifin Corporation (PH)
Fubotv Note3 (Principal)
Teck Resou CLB (TECK)
Constellation Energy (CEG)
Broadcom (AVGO)
Norfolk Southern (NSC)
NVIDIA Corporation (NVDA)

View all positions for UBS O'Connor

Top funds holding Carmell Therapeutics Corp - US

UBS O'Connor
Antara Capital
Balyasny Asset Management
OZ Management
Highbridge Capital Management
Millennium Management
CNH Partners
Exos Asset Management
Citadel Advisors
Walleye Trading Advisors
Saba Capital Management
Whitebox Advisors
Clear Street
UBS Group
Ancora Advisors

View all funds holding Carmell Therapeutics Corp - US